Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Plos Medicine|December 10, 2019
Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysisJan Menne, Eva Dumann, Hermann Haller, et al.Kidney International|May 24, 2020
Is ravulizumab the new treatment of choice for atypical hemolytic uremic syndrome (aHUS)?Jan MenneExpert Review of Cardiovascular Therapy|October 27, 2012
Update on the ROADMAP clinical trial report: olmesartan for the prevention or delay of microalbuminuria development in type 2 diabetesChristos Chatzikyrkou, Jan MenneDrugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Fixed-dose lercanidipine/enalapril for hypertensionJan Menne, Hermann HallerJournal of Hypertension|July 10, 2010
Awareness and behaviour of European physicians in relation to microalbuminuria and organ damage: an ESH-endorsed surveyHermann Haller, Jan Menne, Giuseppe ManciaMedizinische Klinik (Munich, Germany : 1983)|August 25, 2009
[Hypertension 2007-2008]Christos Chatzikyrkou, Jan Menne, Hermann HallerJournal of Hypertension|July 17, 2010
Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockadeJan Menne, Christos Chatzikyrkou, Hermann HallerJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 4, 2009
How to achieve renal protection in the light of ONTARGET?Christos Chatzikyrkou, Jan Menne, Hermann HallerPageof 10